Cargando…
Construction of a bivalent vaccine against anthrax and smallpox using the attenuated vaccinia virus KVAC103
BACKGROUND: Anthrax and smallpox are high-risk infectious diseases, and considered as potential agents for bioterrorism. To develop an effective countermeasure for these diseases, we constructed a bivalent vaccine against both anthrax and smallpox by integrating a gene encoding protective antigen (P...
Autores principales: | Park, Deok Bum, Ahn, Bo-Eun, Son, Hosun, Lee, Young-Ran, Kim, Yu-Ri, Jo, Su Kyoung, Chun, Jeong-Hoon, Yu, Jae-Yon, Choi, Myung-Min, Rhie, Gi-eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938549/ https://www.ncbi.nlm.nih.gov/pubmed/33685392 http://dx.doi.org/10.1186/s12866-021-02121-5 |
Ejemplares similares
-
Vaccinia and Smallpox
Publicado: (1901) -
Vaccinia and Smallpox
Publicado: (1855) -
Human Anthrax Vaccine Development in Korea National Institute of Health
por: Rhie, Gi-eun
Publicado: (2011) -
Generalized Vaccinia 2 Days after Smallpox Revaccination
por: Miller, James R., et al.
Publicado: (2003) -
A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate
por: Jeon, Jun Ho, et al.
Publicado: (2021)